Remove Aging and mental health Remove Genetics and mental health Remove Pharmaceuticals
article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

You’re also an author, and you’ve written on topics such as aging, genetics, mental representation, biological functions, mechanisms in science, and the concept of information in neuroscience. So why do we call schizophrenia a mental disorder, but not believing in conspiracy theories?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Criticisms That Establishment Psychiatry Can and Cannot Tolerate

Mad in America

Establishment psychiatry does acknowledge that emotional suffering and behavioral disturbanceswhat it calls mental illnesseshave biological-psychological-social roots. medical schools. Worldwide, there are parallels to U.S. Iatrogenesis , which is defined as illness or injury caused by medical treatment.

article thumbnail

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

Mad in America

Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five de­cades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.

article thumbnail

Context and Care vs. Isolate and Control: An Interview on the Dilemmas of Global Mental Heath with Arthur Kleinman

Mad in America

As a Professor of Medical Anthropology at Harvard University’s Department of Global Health and Social Medicine and a Professor of Psychiatry at Harvard Medical School, Kleinman has profoundly influenced how medical professionals understand the interplay between culture, illness, and healing. Listen to the audio of the interview here.

article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

article thumbnail

On Not Becoming David Foster Wallace

Mad in America

I didn’t know Wallace was a poster boy for antidepressant withdrawal because I didn’t know that antidepressant withdrawal was common, or that I would be experiencing it myself and understanding firsthand the hellish bodily and mental feelings that make one long for death, for everything to stop. There are no studies, not yet.